Table. Matched case–control study of a CPE outbreak in a haematological ward, France, January 2017–June 2018 (n = 76).
| Variable | Cases (n = 19) |
Controls (n = 57) |
OR | 95% CI | p |
|---|---|---|---|---|---|
| Median (IQR) | |||||
| Age in years | 58 (40–70) | 63 (55–67) | 1.0 | 0.9–1.0 | 0.38 |
| Length of stay (previous 6 months, in days ) | 28 (13–71) | 54 (27–96) | 1.0 | 1.0–1.0 | 0.11 |
| n (%) | |||||
| Men | 8 (42) | 37 (65) | 0.4 | 0.1–1.2 | 0.10 |
| Haematopoietic stem cell transplantation | 14 (74) | 39 (68) | 1.3 | 0.4–4.3 | 0.65 |
| Antibiotic exposure (previous month) | 18 (95) | 45 (80) | 4.5 | 0.5–36.6 | 0.17 |
| Immunosuppressive therapy (previous month) | 17 (89) | 51 (89) | 1.0 | 0.2–5.3 | 1.00 |
| Hospitalisation in a room with OXA-48 CPE-positive toilet | 14 (74) | 15 (26) | 6.2 | 2.0–19.6 | 0.002 |
CI: confidence interval; CPE: carbapenemase-producing Enterobacterales; IQR: interquartile range; OR: odds ratio.
Multiple variables can apply to more than one case.